학술논문
Health‑related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post‑transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone
Document Type
Article
Author
Kubicki, T.; Derman, B.A.; Jakubowiak, A.J.; Nowicki, A.; Szczepaniak, T.; Łojko‑Dankowska, A.; Matuszak, M.; Gil, L.; Dytfeld, D.; Jamroziak, K.; Puła, B.; Końska, A.; Robak, P.; Mikulski, D.; Robak, T.; Czyż, J.; Szukalski, Ł.; Tyczyńska, A.; Zaucha, J.M.; Druzd‑Sitek, A.; Walewski, J.; Giannopoulos, K.; Czabak, O.; Wróbel, T.; Major, A.; Kruk‑Kwapisz, D.
Source
In: Polish Archives of Internal Medicine . (Polish Archives of Internal Medicine, 28 May 2024, 134(5))
Subject
Language
English
ISSN
18979483
00323772
00323772